Christopher W Dukes (Christopher Dukes)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Top Venues

Molecular cancer therapeutics

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-human stage III/IV melanoma clinical trial of immune priming agent IFx-Hu2.0. Molecular cancer therapeutics (2024)
Joseph Markowitz, Michael Shamblott, Andrew S Brohl, Amod A Sarnaik, Zeynep Eroglu, Nikhil I Khushalani, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward T Garcia, Ashraf Dehlawi, Pei-Ling Chen, Deanryan B De Aquino, Vernon K Sondak, Ahmad A Tarhini, Youngchul Kim, Patricia Lawman, Shari A Pilon-Thomas
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0. Molecular cancer therapeutics 23 (8) (2024)
Christopher W Dukes, Marine Potez, Jeffrey Lancet, Barbara J Kuter, Junmin Whiting, Qianxing Mo, Brett Leav, Haixing Wang, Julie S Vanas, Christopher L Cubitt, Kimberly Isaacs-Soriano, Kayoko Kennedy, Julie Rathwell, Julian Diaz Cobo, Wesley O'Nan, Bradley Sirak, Ning Dong, Elaine Tan, Patrick Hwu, Anna R Giuliano, Shari Pilon-Thomas
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients. Vaccines 12 (1) (2023)
Christopher W Dukes, Marine Potez, Jeffrey Lancet, Barbara J Kuter, Junmin Whiting, Qianxing Mo, Brett Leav, Haixing Wang, Julie S Vanas, Christopher L Cubitt, Kimberly Isaacs-Soriano, Kayoko Kennedy, Julie Rathwell, Julian Diaz Cobo, Wesley O'Nan, Bradley Sirak, Ning Dong, Elaine Tan, Patrick Hwu, Anna R Giuliano, Shari Pilon-Thomas
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients. Vaccines 12 (1) (2023)
Anna Giuliano, Barbara Kuter, Shari Pilon-Thomas, Junmin Whiting, Qianxing Mo, Brett Leav, Bradley Sirak, Christopher Cubitt, Christopher W Dukes, Kimberly Isaacs-Soriano, Kayoko Kennedy, Somedeb Ball, Ning Dong, Akriti Jain, Patrick Hwu, Jeffrey E Lancet
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients. Cancer communications (London, England) (2023)
Christopher W Dukes, Marine Potez, Jeffrey Lancet, Barbara J Kuter, Junmin Whiting, Qianxing Mo, Brett Leav, Haixing Wang, Julie S Vanas, Christopher L Cubitt, Kimberly Isaacs-Soriano, Kayoko Kennedy, Julie Rathwell, Julian Diaz Cobo, Wesley O'Nan, Bradley Sirak, Ning Dong, Elaine Tan, Patrick Hwu, Anna R Giuliano, Shari Pilon-Thomas
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients. Vaccines 12 (1) (2023)
Christopher W Dukes, Marine Potez, Jeffrey Lancet, Barbara J Kuter, Junmin Whiting, Qianxing Mo, Brett Leav, Haixing Wang, Julie S Vanas, Christopher L Cubitt, Kimberly Isaacs-Soriano, Kayoko Kennedy, Julie Rathwell, Julian Diaz Cobo, Wesley O'Nan, Bradley Sirak, Ning Dong, Elaine Tan, Patrick Hwu, Anna R Giuliano, Shari Pilon-Thomas
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients. Vaccines 12 (1) (2023)